Related Experiment Videos
Hepatic drug disposition in multiple organ failure
W Schregel1, H D Kuntz, M Vitt
1Department of Anesthesiology and Intensive Care Medicine, Knappschaftskrankenhaus, Ruhr-Uni-Bochum, W. Germany.
Acta Anaesthesiologica Scandinavica
|November 1, 1988
Summary
Drug elimination in patients with multiple organ failure can be affected. While glucuronidation remains intact, drug monitoring is crucial for optimizing therapy and improving patient outcomes in sepsis.
Area of Science:
- Pharmacology
- Hepatology
- Critical Care Medicine
Background:
- Multiple organ failure (MOF) in sepsis presents complex challenges in drug management.
- Hepatic drug disposition is critical for effective pharmacotherapy but can be altered during critical illness.
Purpose of the Study:
- To evaluate key hepatic drug disposition functions in patients with septic multiple organ failure.
- To assess the impact of MOF on specific drug elimination pathways.
Main Methods:
- Studied 15 patients with septic multiple organ failure.
- Measured hepatic functions using test substances: galactose, indocyanine green, theophylline, and 4-methylumbelliferon.
Main Results:
- Glucuronidation pathways were not impaired in any patient.
- Flow-limited and capacity-limited drug elimination processes were found to be potentially influenced.
Conclusions:
- Hepatic drug elimination can be altered in septic MOF, necessitating careful management.
- Intensive drug monitoring and clinical observation are essential for improving therapeutic outcomes in these critically ill patients.